Komori
Share Issuance and Disposal4593HEALIOS K.K.Pharmaceuticals

Notice Regarding the Finalization of the Terms of the Gratis Stock Options (28th Series of Share Acquisition Rights)

The previously undetermined issuance terms for the 28th Stock Acquisition Rights, resolved on 17 June 2026, including the eligible recipients, allocation amounts and exercise price, have been finalized. A total of 12,471 rights, representing 1,247,100 underlying shares, will be allocated free of charge to the Company's directors, executive officers and employees, and the directors and employees of its subsidiaries.

Worth reading
42Recurring
Scored from 3 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
1247100
Shares
Wording
Definitive
How definitive the wording is.

Details of issuance or disposal

Issuance of gratis stock options (the 28th Stock Acquisition Rights)

発行・処分する株式数1,247,100Shares

1,247,100 common shares

Intended allottee
Name Directors of the company / Number of Employees 3 / Number of stock acquisition rights 652 rights, Name The Company's executive officers, including directors serving concurrently as executive officers / Number of Employees 4 / Number of stock acquisition rights 1,001 rights, Name The Company's employees / Number of Employees 50 / Number of stock acquisition rights 9,568 rights, Name Directors of the company's subsidiaries / Number of Employees 1 / Number of stock acquisition rights 500 rights, Name Employees of the company's subsidiaries / Number of Employees 1 / Number of stock acquisition rights 750 rights
Terms of the stock acquisition rights
Exercise price
The initial exercise price is ¥28,600 per Stock Acquisition Right (¥286 per share). The adjustment provisions and adjustment floor are Not disclosed
Number of Stock Acquisition Rights
Total issuance: 12,471 rights. Outstanding unexercised rights: Not disclosed
Categories and Number of Persons Covered
Category Directors of the company / Number of Employees 3 / Number allocated 652 rights, Category The Company's executive officers, including directors serving concurrently as executive officers / Number of Employees 4 / Number allocated 1,001 rights, Category The Company's employees / Number of Employees 50 / Number allocated 9,568 rights, Category Directors of the company's subsidiaries / Number of Employees 1 / Number allocated 500 rights, Category Employees of the company's subsidiaries / Number of Employees 1 / Number allocated 750 rights
Details of issuance or disposal
ItemDetails
Type of issuance or disposalIssuance of gratis stock options (the 28th Stock Acquisition Rights)
Number of shares to be issued or disposed of1,247,100 common shares
Intended allotteeName Directors of the company / Number of Employees 3 / Number of stock acquisition rights 652 rights, Name The Company's executive officers, including directors serving concurrently as executive officers / Number of Employees 4 / Number of stock acquisition rights 1,001 rights, Name The Company's employees / Number of Employees 50 / Number of stock acquisition rights 9,568 rights, Name Directors of the company's subsidiaries / Number of Employees 1 / Number of stock acquisition rights 500 rights, Name Employees of the company's subsidiaries / Number of Employees 1 / Number of stock acquisition rights 750 rights
Exercise priceThe initial exercise price is ¥28,600 per Stock Acquisition Right (¥286 per share). The adjustment provisions and adjustment floor are Not disclosed
Number of Stock Acquisition RightsTotal issuance: 12,471 rights. Outstanding unexercised rights: Not disclosed
Categories and Number of Persons CoveredCategory Directors of the company / Number of Employees 3 / Number allocated 652 rights, Category The Company's executive officers, including directors serving concurrently as executive officers / Number of Employees 4 / Number allocated 1,001 rights, Category The Company's employees / Number of Employees 50 / Number allocated 9,568 rights, Category Directors of the company's subsidiaries / Number of Employees 1 / Number allocated 500 rights, Category Employees of the company's subsidiaries / Number of Employees 1 / Number allocated 750 rights
Items this document does not state (22)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyDilution RateTotal number of issued sharesBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMost recent equity financingMajor shareholders after the offeringImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The rights will be issued as stock options to the Company's directors, executive officers and employees and the directors and employees of its subsidiaries. No specific reason for finalizing the issuance terms is stated.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Finalization of the Terms of the Gratis Stock Options (28th Series of Share Acquisition Rights) | HEALIOS K.K. (4593) timely disclosure | Komori